Table 1. Association between the expression of MORC2 and clinicopathologic characteristics in 44 patients with CCA.
Clinical characteristics | Total | MORC2 expression | P-value | |
Negative-Low | High | |||
Age | 0.908 | |||
≤ 60 years | 24 | 8 | 16 | |
> 60 years | 20 | 7 | 13 | |
Gender | 0.939 | |||
Male | 29 | 10 | 19 | |
Female | 15 | 5 | 10 | |
Serum CA19-9 level | 0.009 | |||
>37 U/ml | 29 | 6 | 23 | |
≤37 U/ml | 15 | 9 | 6 | |
Histologic differentiation | 0.914 | |||
Well | 13 | 4 | 9 | |
Moderate | 18 | 6 | 12 | |
Poor | 13 | 5 | 8 | |
TNM stage | 0.003 | |||
I-II | 16 | 10 | 6 | |
III-IV | 28 | 5 | 23 | |
Lymph node invasion | 0.004 | |||
Present | 25 | 4 | 21 | |
Absent | 19 | 11 | 8 |